Borchmann, Peter <br/><br/>
The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered.  [electronic resource] 

 -  HemaSphere  Jun 2018 
 - e52 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>2572-9241 
<br/><br/><label>Standard No.: </label>10.1097/HS9.0000000000000052  doi